TOWARD DEFINING AND APPLYING A HIGHER STANDARD OF QUALITY FOR MEDICATION USE IN THE UNITED-STATES

被引:14
作者
MANASSE, HR
机构
关键词
D O I
10.1093/ajhp/52.4.374
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:374 / 379
页数:6
相关论文
共 23 条
[1]  
Baker K R, 1994, Am Pharm, VNS34, P60
[2]  
COWLEY G, 1990, NEWSWEEK, V115, P82
[3]  
DAVIS NM, 1981, MEDICATION ERRORS CA
[4]  
DUKES MNG, 1988, RESPONSIBILITY DRUG
[5]  
GADOMSKI A, 1994, JAMA-J AM MED ASSOC, V272, P1063
[6]  
GLASER M, 1994, DRUG TOP 0321
[7]  
HEENAN J, 1994, MED INTERFACE, V7
[8]   INTRODUCING MEDWATCH - A NEW APPROACH TO REPORTING MEDICATION AND DEVICE ADVERSE-EFFECTS AND PRODUCT PROBLEMS [J].
KESSLER, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (21) :2765-2768
[9]   OVER-THE-COUNTER MEDICATION USE AMONG US PRESCHOOL-AGE CHILDREN [J].
KOGAN, MD ;
PAPPAS, G ;
YU, SM ;
KOTELCHUCK, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (13) :1025-1030
[10]  
MACKEIGAN LD, 1994, J RES PHARM EC, P69